Repare Therapeutics (NASDAQ: RPTX)
$1.38
(7.8%)
$0.10
Price as of January 10, 2025, 4:00 p.m. ET
Repare Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Repare Therapeutics Company Info
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
News & Analysis
Featured Article
Wall Street Thinks This Cathie Wood Stock Could Jump by 187%
This small-cap biotech stock holds enormous growth potential.
George Budwell | Aug 16, 2023
Featured Article
Why Repare Therapeutics Stock Is Skyrocketing Today
The company just announced a major collaboration with multinational pharmaceutical giant Roche.
Keith Speights | Jun 2, 2022
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.